Well, now I think Wayne was right to bet the house on TAVR, let's face it the patch business was never going to be the company maker the way things are going.
To be able to go to human trials so soon compared to other products on the market that took years to advance to human trials is a testament by itself to the superiority of the design and tissue of our TAVR, this is HUGE!
Now my next hope is a quick deal with one of the two majors to fund it, reading that they will be doing human trials soon tells me that a TAVR deal is just around the corner.
Very welcome news finally, hopefully the drought is broken.
this is great news to patients and shareholders alike.
Ann: Promising Interim Results from TAVR Animal Study, page-6
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.70 |
Change
-0.300(1.58%) |
Mkt cap ! $359.4M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.62 | $180.3K | 9.596K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 475 | $18.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.91 | 100 | 1 |
View Market Depth
| Last trade - 14.41pm 20/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |